1. Endogenously produced urokinase-type plasminogen activator is a major determinant of the basal level of activated ERK/MAP kinase and prevents apoptosis in MDA-MB-231 breast cancer cells
   Zhong Ma et al, 2001, Journal of Cell Science CrossRef
2. Renal Urokinase-Type Plasminogen Activator (uPA) Receptor but not uPA Deficiency Strongly Attenuates Ischemia Reperfusion Injury and Acute Kidney Allograft Rejection
   Faikah Gueler et al, 2008, The Journal of Immunology CrossRef